Dren Bio, Inc.

Dren Bio, Inc. company information, Employees & Contact Information

Explore related pages

Dren Bio, Inc. email format Dren Bio, Inc. management contacts

Related company profiles:

Dren Bio is a Foster City, CA based biotechnology company, developing power protein-based technologies to deplete pathogenic cells and agents in numerous diseases.

Company Details

Employees
101
Address
384 Foster City Blvd, Foster City,california 94404,united States
Industry
Biotechnology
Website
drenbio.com
Keywords
Biotechnology and Antibody.
HQ
Foster City, California
Competitors
Sanofi, Revolution Medicines, 3T Biosciences, Arsenal Biosciences, Inc., Xaira Therapeutics, Allogene Therapeutics, Firefly Bio, Kyverna Therapeutics, Asher Biotherapeutics, Allakos Inc.
Looking for a particular Dren Bio, Inc. employee's phone or email?

Dren Bio, Inc. Questions

News

Press Release: Sanofi to acquire Dren Bio’s bispecific - GlobeNewswire

Press Release: Sanofi to acquire Dren Bio’s bispecific GlobeNewswire

Sanofi pays $600M upfront for Dren Bio's bispecific in latest immunology play - Fierce Biotech

Sanofi pays $600M upfront for Dren Bio's bispecific in latest immunology play Fierce Biotech

Sanofi signs $1.9bn deal to buy Dren Bio autoimmune drug - pharmaphorum

Sanofi signs $1.9bn deal to buy Dren Bio autoimmune drug pharmaphorum

Sanofi to acquire Dren Bio's immunology unit - Reuters

Sanofi to acquire Dren Bio's immunology unit Reuters

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager DR-201 - European Biotechnology Magazine

Sanofi to acquire Dren Bio’s bispecific myeloid cell engager DR-201 European Biotechnology Magazine

Press Release: Sanofi completes acquisition of DR-0201 - GlobeNewswire

Press Release: Sanofi completes acquisition of DR-0201 GlobeNewswire

Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer - Business Wire

Dren Bio Announces Strategic Collaboration with Novartis to Develop Novel Targeted Myeloid Engagers for Cancer Business Wire

Sanofi outlays $1.9bn to purchase Dren Bio’s bispecific antibody - Pharmaceutical Technology

Sanofi outlays $1.9bn to purchase Dren Bio’s bispecific antibody Pharmaceutical Technology

Wilson Sonsini Advises Dren Bio on Collaboration with Novartis - Wilson Sonsini

Wilson Sonsini Advises Dren Bio on Collaboration with Novartis Wilson Sonsini

Sanofi pays $600M upfront for Dren Bio's bispecific myeloid cell engager - FirstWord Pharma

Sanofi pays $600M upfront for Dren Bio's bispecific myeloid cell engager FirstWord Pharma

Cargo Therapeutics to exit San Carlos lease, pay $35.8 million to Alexandria as Dren Bio takes over space - The Business Journals

Cargo Therapeutics to exit San Carlos lease, pay $35.8 million to Alexandria as Dren Bio takes over space The Business Journals

Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease - BioSpace

Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease BioSpace

Serbian biotech Dren Bio sold to Sanofi for $1.9bn - IntelliNews

Serbian biotech Dren Bio sold to Sanofi for $1.9bn IntelliNews

Sanofi wagers $600M on a dual-targeting antibody drug for autoimmune disease - BioPharma Dive

Sanofi wagers $600M on a dual-targeting antibody drug for autoimmune disease BioPharma Dive

Novartis pays $150M upfront, including $25M in equity, for Dren Bio’s bispecifics - Endpoints News

Novartis pays $150M upfront, including $25M in equity, for Dren Bio’s bispecifics Endpoints News

Dren Bio - The Pharma Letter

Dren Bio The Pharma Letter

Dren Bio Announces $65 Million Series B Financing to Advance its Lead Asset into the Clinic and to Accelerate Development of New Product Candidates from its Targeted Myeloid Engager and Phagocytosis Platform - Business Wire

Dren Bio Announces $65 Million Series B Financing to Advance its Lead Asset into the Clinic and to Accelerate Development of New Product Candidates from its Targeted Myeloid Engager and Phagocytosis Platform Business Wire

Novartis hopes for better luck with bispecifics via $150M upfront Dren Bio deal - Fierce Biotech

Novartis hopes for better luck with bispecifics via $150M upfront Dren Bio deal Fierce Biotech

Dren Bio and Novartis to develop bispecific antibodies for cancer - Pharmaceutical Technology

Dren Bio and Novartis to develop bispecific antibodies for cancer Pharmaceutical Technology

Novartis, Dren Bio Ink Potential $3B Deal for Anti-Myeloid Bispecific Antibodies for Cancer - BioSpace

Novartis, Dren Bio Ink Potential $3B Deal for Anti-Myeloid Bispecific Antibodies for Cancer BioSpace

Sanofi to Acquire DR-0201 from Dren Bio - Contract Pharma

Sanofi to Acquire DR-0201 from Dren Bio Contract Pharma

Novartis and Dren Bio enter bispecific antibody partnership worth up to $3bn - PMLiVE

Novartis and Dren Bio enter bispecific antibody partnership worth up to $3bn PMLiVE

With $1B already in for Dren Bio, Pfizer adds to pile in $65M financing - Fierce Biotech

With $1B already in for Dren Bio, Pfizer adds to pile in $65M financing Fierce Biotech

Sanofi to buy immunology drug from Serbian-founded Dren Bio - SeeNews

Sanofi to buy immunology drug from Serbian-founded Dren Bio SeeNews

$1 Billion Pfizer-Dren Bio Deal Highlights Another Day of Collaborations - BioSpace

$1 Billion Pfizer-Dren Bio Deal Highlights Another Day of Collaborations BioSpace

Pfizer-Backed Dren Nets $65M to Advance Lead Asset to Clinic - BioSpace

Pfizer-Backed Dren Nets $65M to Advance Lead Asset to Clinic BioSpace

Companies like Dren Bio, Inc.

Sanofi logo - Similar company to Dren Bio, Inc.

Sanofi

88.33K
Kyverna Therapeutics logo - Similar company to Dren Bio, Inc.

Kyverna Therapeutics

138
Revolution Medicines logo - Similar company to Dren Bio, Inc.

Revolution Medicines

737
Allakos Inc logo - Similar company to Dren Bio, Inc.

Allakos Inc

41
3T Biosciences logo - Similar company to Dren Bio, Inc.

3T Biosciences

28
Allogene Therapeutics logo - Similar company to Dren Bio, Inc.

Allogene Therapeutics

222
Arsenal Biosciences, Inc. logo - Similar company to Dren Bio, Inc.

Arsenal Biosciences,...

298
Firefly Bio logo - Similar company to Dren Bio, Inc.

Firefly Bio

32
Asher Biotherapeutics logo - Similar company to Dren Bio, Inc.

Asher Biotherapeutics

26
Xaira Therapeutics logo - Similar company to Dren Bio, Inc.

Xaira Therapeutics

174

Top Dren Bio, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant